Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 4/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.45 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.43 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.43 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.43 |
| ▸ | KCND3 | Q9UK17 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6000906 | 1.00 | KCNA5 (0.47) | KCNA5KCNH2KDM4ELMNAALOX12 | |
| SCHEMBL28331181 | 1.00 | KCNA5 (0.47) | KCNA5KCNH2KDM4ELMNAALOX12 | |
| SCHEMBL7293012 | 0.98 | KCNA5 (0.49) | KCNA5KCNH2KDM4ELMNAALOX12 | |
| SCHEMBL8986648 | 0.98 | KCNA5 (0.49) | KCNA5KCNH2KDM4ELMNAALOX12 | |
| Hydrochloric Acid SCHEMBL8608055 | 0.97 | KCNA5 (0.47) | KCNA5KCNH2KDM4ELMNAALOX12 | |
| SCHEMBL7275282 | 0.93 | KCNA5 (0.50) | KCNA5KCNH2KDM4ELMNAALOX12 | |
| SCHEMBL1526122 | 0.93 | KCNA5 (0.50) | KCNA5KCNH2KDM4ELMNAALOX12 | |
| SCHEMBL30596267 | 0.87 | KCNA5 (0.51) | KCNA5KCNH2KDM4ELMNASMN1; SMN2 | |
| SCHEMBL2230732 | 0.87 | KCNA5 (0.51) | KCNA5KCNH2KDM4ELMNASMN1; SMN2 | |
| SCHEMBL7687239 | 0.85 | LMNA (0.44) | KDM4ELMNAALOX12SMN1; SMN2USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9592226-B2 | Solenopsin and derivatives, therapeutic compositions; and methods related thereto | EMORY UNIVERSITY (US) | 2017-03-14 | — | — | US | disclosed |
| US-20150306082-A1 | SOLENOPSIN AND DERIVATIVES, THERAPEUTIC COMPOSITIONS, AND METHODS RELATED THERETO | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-10-29 | — | — | US | disclosed |
| US-20140335079-A1 | SOLENOPSIN AND DERIVATIVES, THERAPEUTIC COMPOSITIONS, AND METHODS RELATED THERETO | EMORY UNIVERSITY (US) | 2014-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150306082-A1 | SOLENOPSIN AND DERIVATIVES, THERAPEUTIC COMPOSITIONS, AND METHODS RELATED THERETO | AGPS, CYP27A1, CYP11A1 | KCNA5 3197/4885KCNH2 4485/4885KDM4E 2499/4885 |
| US-20140335079-A1 | SOLENOPSIN AND DERIVATIVES, THERAPEUTIC COMPOSITIONS, AND METHODS RELATED THERETO | AGPS, CYP27A1, CYP11A1 | KCNA5 3197/4885KCNH2 4485/4885KDM4E 2499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.